as 11-22-2024 4:00pm EST
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | PLEASANTON |
Market Cap: | 33.1B | IPO Year: | 2013 |
Target Price: | $237.25 | AVG Volume (30 days): | 1.0M |
Analyst Decision: | Buy | Number of Analysts: | 24 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 3.75 | EPS Growth: | 12.96 |
52 Week Low/High: | $165.12 - $240.68 | Next Earning Date: | 12-05-2024 |
Revenue: | $2,573,649,000 | Revenue Growth: | 15.29% |
Revenue Growth (this year): | 17.32% | Revenue Growth (next year): | 12.01% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Schwenger Thomas D. | VEEV | Pres. & Chief Customer Officer | Nov 8 '24 | Sell | $240.01 | 1,126 | $270,251.94 | 27,013 |
VEEV Breaking Stock News: Dive into VEEV Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Zacks
2 days ago
PR Newswire
3 days ago
Medical Device Network
3 days ago
PR Newswire
4 days ago
Zacks
4 days ago
MT Newswires
5 days ago
PR Newswire
5 days ago
The information presented on this page, "VEEV Veeva Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.